NCT00329498View on ClinicalTrials.gov

L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes

PHASE2SuspendedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

May 31, 1998

Study Completion Date

August 31, 2005

Conditions

Acute Myeloid LeukemiaMyelodysplastic Syndrome

Interventions

DRUG

L-Ascorbic Acid

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Jin Yang Pharmaceutical

All Listed Sponsors

collaborator

Jin Yang Pharmaceutical

INDUSTRY

lead

Samsung Medical Center

OTHER